The checklist includes a number of questions that will help companies to assess the level of completion and consistency of the various sections in their applications. More information can be found in the updated Pre-authorisation guidance questions and answers (Q&A) on the website.
In addition, EMA has also updated the Q&A section on inspections and compliance with an updated form on good clinical practice (GCP) as well as clarification on statements required in the cover letter for good manufacturing practice (GMP). These will help companies to structure the relevant information required for the organisation of future inspections.
After completion, EMA will analyse the result of the pilot and inform stakeholders about the conclusion in the second half of 2019.